Krystal Biotech Inc

KRYS · NASDAQ

Biological Product (except Diagnostic) Manufacturing · US

Krystal Biotech, Inc. is a pivotal-stage gene therapy company leveraging its novel, redosable gene therapy platform and in-house manufacturing capabilities to develop therapies to treat serious rare diseases.

Market Data

Price $346.58 +9.56 (+2.84%)

Market Cap$9.71B

P/E Ratio40.23

EPS$—

52W High$382.54

52W Low$136.73

Beta0.48

Data from Finnhub · Updated Aug 23, 2026